Skip to main content
The Egyptian Heart Journal

Table 5 Correlation between QRS width change and LV EF (%) after 6 months of S/V therapy

From: Unlocking the potential of sacubitril/valsartan therapy in improving ECG and echocardiographic parameters in heart failure patients with reduced ejection fraction (HErEF)

QRS width (ms)

LV EF %

R

p-value

 

− 0.243*

0.016

  1. LV EF, left ventricular systolic ejection fraction; ms, millisecond
  2. *Spear Mann correlation coefficient
Back to article page